HBIO vs IRIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 17, 2026

HBIO

54.7
AI Score
VS
HBIO Wins

IRIX

43.6
AI Score

Investment Advisor Scores

HBIO

55score
Recommendation
HOLD

IRIX

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO IRIX Winner
Revenue 20.75M 11.80M HBIO
Net Income -3.42M -524,000 IRIX
Gross Margin 59.0% 40.2% HBIO
Net Margin -16.5% -4.4% IRIX
Operating Income -1.17M -324,000 IRIX
ROE -34.1% -11.1% IRIX
ROA -4.4% -1.9% IRIX
Total Assets 77.94M 28.27M HBIO
Cash 7.10M 4.59M HBIO
Current Ratio 1.99 1.92 HBIO
Free Cash Flow -1.09M -1.44M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +0.8% · 3M: -4.4% IRIX 1M: -29.9% · 3M: -20.4%

Current Technical Phase

HBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $6.10

IRIX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 16

RSI (14): 16.0 · Price: $0.82

Fundamentals Snapshot

Metric HBIO IRIX
Market Cap
Forward P/E 13.9 41.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.4%
Operating Margin 0.0% 0.0%
EPS -2.15 -0.19
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.